Century Therapeutics Inc (IPSC)
3.07
-0.30
(-8.90%)
USD |
NASDAQ |
May 08, 16:00
3.05
-0.02
(-0.65%)
After-Hours: 20:00
Century Therapeutics Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.0371 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0338 |
| September 30, 2022 | 0.0308 |
| June 30, 2022 | 0.0282 |
| March 31, 2022 | 0.0259 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2023
0.0371
Maximum
Mar 2023
0.0195
Average
0.027
Median
Debt to Equity Ratio Benchmarks
| Verastem Inc | -- |
| First Wave BioPharma Inc | -- |
| Gritstone Bio Inc | 0.7742 |
| Allogene Therapeutics Inc | 0.00 |
| Mirum Pharmaceuticals Inc | 1.232 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 360.69M |
| Total Liabilities (Quarterly) | 175.94M |
| Shareholders Equity (Quarterly) | 184.75M |
| Current Ratio | 9.918 |
| Net Debt Paydown Yield | 1.02% |